The close encounter between alpha-synuclein and mitochondria
Patients covered by Medicare, Medicaid, VA, or TRICARE are strictly ineligible
Our team of board-certified physicians and experienced healthcare providers are dedicated to delivering exceptional, patient-centered care in a welcoming and compassionate environment
The patients were randomized into four groups: three received different doses of tirzepatide 5, 10, and 15mg per week and the fourth received 1mg semaglutide
This is one of the most interesting potential applications, though formal head-to-head data in this population is limited
Media coverage examining injectable versus oral GLP-1 access pathways reflects growing consumer interest in how format differences influence treatment preferences